Making a Difference – Innovations in Infection Prevention 2020
C Diff Foundation acknowledges the following organizations “Making a Difference”
In the Infection Prevention community, with their innovative products, services, and
technologies addressing infection prevention.
Applied Silver Innovation: SilvaClean® Technology
SilvaClean chemistry is EPA-approved as a laundry additive with residual activity
against post-laundry contamination.
The SilvaClean system is a dispensing device enabled by the Internet of Things (IoT)
that doses the EPA-approved SilvaClean chemistry onto textiles, leaving fabrics with
residual antimicrobial properties even after laundering (e.g. in storage, during handling
and in use). http://www.appliedsilver.com/
Intellego Technologies Innovation: UVC Dosimeter™
Able to measure specific wavelengths of UVC radiation.
Can be correlated with a log reduction of microbiology samples e.g. MRSA and C. diff.
Proven functionality through hospital testing. http://intellego-technologies.com/
Synexis Biodefense Systems Innovation:Synexis™ Microorganism Reduction Systems
Patented Dry Hydrogen Peroxide (DHP) technology uses a building’s ambient humidity
and oxygen to continuously achieve sustainable reduction of microbial challenges from
viruses, bacteria, and mold in the air and on workplace surfaces.
DHP technology is inexpensive, highly scalable, and can be installed standalone or in
existing HVAC systems. https://synexis.com/
Early Bird Registration is in progress — save over 20% until June 2020.
Congratulations to the organizations dedicated in preventing infections and for
developing products, services, and technology capable to ward off harmful bacteria in
all areas of health care and commercial environments. We are truly grateful for the
innovative measures taken to accomplish this goal.
C Diff Foundation, a 501(c) (3) non-profit organization, established in 2012, and
comprised of 100% volunteering professionals dedicated at supporting public health
through education and advocating for C. difficile infection (CDI) prevention, treatments,
clinical trials, diagnostics, and environmental safety worldwide.
(Disclaimer: C Diff Foundation declares no conflict of interest; no funds or influence
were provided to C Diff Foundation by any parties.)
Shop Amazon to support the many programs and educational workshops provided by the C Diff Foundation worldwide —
It’s a pleasure to share the new way to give to the C Diff Foundation. Amazon will share a portion of the proceeds from your purchases with the C Diff Foundation. While you are shopping on-line you are also donating, and we are grateful.
Here is how it works:
* Shop Amazon through AmazonSmile C Diff Foundation
The Global C. difficile Congress FREE Webinar will take place on November 11th at 8:00 a.m. Eastern Time will broaden existing knowledge surrounding C. difficile infection (CDI) prevention, treatments, and environmental safety worldwide. The drive and passion takes us forward in promoting the practical and technical advancements taking place across the globe. Healthcare Professionals from every area of expertise, will discuss the control and treatment options, the healthcare perspectives, antibiotic-resistance stewardship programs, and much more to raise awareness and share successful implementations and guidelines.
The Global C. difficile Congress will be eight sessions presented by topic experts – in four hours – in one day – with goals to change the C. difficile world with a common focus; To
improve C. diff. infection prevention, treatments, and environmental safety in the healthcare communities worldwide.
Twitter chats and tweets take place in honor of the
Global C. diff. Awareness Campaign From November 1st throughout the month.
There will be a #CdiffTwitterChat
Join Us on NOVEMBER 18TH at 3:30 p.m. Eastern Time with International Infectious Disease Expert, Dr. Hudson Garrett Jr. for a real-time Question and Answer Twitter Chat about Clostridium difficile infection and disease. Questions are welcomed from both patients and healthcare providers. Registration is complimentary to all those interested. Click on the link below for more information:
We applaud our Volunteer Patient Advocates around the globe who continue sharing life-saving information from villages to cities organizing meetings during the month of November to reach a little higher, speak a little louder and elevate C. difficile infection awareness, prevention, treatments, and environmental safety for everyone to witness a decrease in C. diff. infections worldwide. Each Volunteer is a special leaf, on each branch of the growing C Diff Foundation tree. Our sincere gratitude to each of our Volunteers worldwide!
As many people in the healthcare and infectious disease industry are aware, Clostridium difficile (C. difficile) infections remain a significant problem
in the United States. The U.S. Centers for Disease Control and Prevention (CDC) reports that about 250,000 C. difficile infections occur per year that require hospital treatment or affect those already hospitalized. On top of that, each year an estimated 14,000 people die
from C. difficile infection.
The severity of this problem is one reason why I am proud to join the C Diff Foundation’s Medical Advisory Board. The C Diff Foundation is dedicated in educating and advocating for C. difficile infection prevention, treatments, environmental safety products, and support worldwide while providing support for those affected by a C. difficile infection , raiseis awareness about the problem and works to help healthcare
providers, facilities, patients and their families implement preventative measures worldwide.
Please join me and the C Diff Foundation in celebrating the 4th annual worldwide month long campaign “Raising C. difficile Awareness ” starting Nov. 1st to increase awareness of this life-threatening infection, and spread the word about C. difficile prevention, treatment and environmental safety.
Antibiotic Stewardship – Prescribe and use antibiotics carefully. Unnecessary use can raise infection risks.
Test – If a patient has diarrhea while on antibiotics or after taking them, order a C. difficile test right away to confirm whether he/she is infected.
Isolation Precautions – Immediately isolate patients with confirmed
cases of C. difficile or who are exhibiting symptoms (e.g., diarrhea).
Personal Protective Equipment – Always perform hand hygiene with soap and water before and after contact with infected individuals. Wear gloves and gowns when treating C. difficile patients and ensure that staff uses them properly to avoid cross-contamination risks.
Environmental Decontamination – Clean the facility, especially rooms of patients with C. difficile, with bleach or another EPA-registered spore-killing disinfectant. Make sure you follow manufacturers’ instructions for dilution and contact time, the length of time the surface needs to remain wet for the product to work. Also consider supplementing standard terminal cleaning with an ultraviolet (UV-C) system.
Alert – If a patient with C. difficile transfers, notify the new facility of their condition so they can take the proper precautionary measures.
We are pleased to welcome Ron Romano, RN to the C Diff Foundation Global Network.
Ron Romano, RN presides as Infection Prevention Advocate.
Ron has certifications from the following organizations :
American Association for LTC Nursing – Co-founder Past President – 2007- 2015
American Association for Safe Patient Handling – Board Member 2010-2012
Association for Professionals in Infection Control & Epidemiology – Current Member
Safety Specialist LTC – Certification – Current
C. difficile Infections are no stranger to Ron as his family members have also been touched by this infection. His background in healthcare and passion for Infection Prevention and Epidemiology is an asset to many. Ron is the Owner, President and CEO of Safety Net LLC in Cincinnati, Ohio.
Safety Net is a national healthcare safety consulting and distribution company providing unique product solutions to mitigate risk associated to infections. We serve acute care hospitals, post-acute and home-care. Our solutions protect our healthcare workers and those under their care.
Ron has also been the Past-President in the following organizations:
American Association for LTC Nursing (AALTCN) 07-15 The AALTCN is a professional organization that supports all levels of caregivers providing career ladder with supporting education, certifications and resources. AALTCN has recently merged with the American Association for Nurse Assessment Coordinators to form the largest professional nursing organization in long term care.
Health Education Network – 07-15, Co-owner – President
Health Education Network is a medical publication company that provides Nursing education for all levels of caregivers on a variety of topics for LTC. Certificate programs are available for Staff Development Coordinators, Nurse Assessment Coordinators, Director of Nursing in LTC, RN and LPN in LTC.
National Association Director of Nursing Administration (NADONA/LTC) Cincinnati, Ohio 01-07
NADONA/LTC is a professional organization representing Directors of Nursing, Assistant Directors of Nursing and Clinical Managers in long-term care. NADONA/LTC has 38 state chapters nationally and internationally in Canada.
We welcomeRon to the C Diff Foundation and appreciate his healthcare background to join us in promoting Infection prevention and C. diff. Awareness worldwide with fellow members
The C Diff Foundation Volunteer Patient Advocates; Heather Clark and
her sister, Kimberly Reilly participated at local events over the summer season to educate and advocate
for C. diff. infection prevention, treatments, and environmental safety within the local communities raising C. diff. awareness and saving lives.
On behalf of the C Diff Foundation , we sincerely thank you Heather and Kimberly for your dedication, your time, and for joining the
C Diff Foundation partnering and sharing our global mission.
We are truly grateful to the many special Volunteer Patient Advocates, the special individuals donating their time in “Raising C. diff. Awareness within their communities” around the globe. Thank You!
Heather and Kimberly lost their dear Father from C.diff. involvement. Shortly after his passing, Heather and Kimberly took a stand with the C Diff Foundation and dedicated their time and efforts in “Raising C. diff. Awareness” to help educate, and advocate for this life-threatening infection that played a big part in their Father’s passing.
To listen to Heather’s journey, with fellow C. diff. survivors, – please click on the podcast link below:
Clostridium difficile (C.diff.) is gram-positive, anaerobic, and a spore, rod/spindle-shape,
a common bacterium of the human intestine in 2 – 5%. C diff. becomes a serious gastrointestinal infection when individuals have been exposed to antibiotic therapy, and/or have experienced a long-term hospitalization, and/or have had an extended stay in a long-term care facility. However; the risk of acquiring a C diff. infection (CDI) has increased as it is in the community (Community Acquired CDI) and found in outpatient settings.
There are significant risk factors in patients who are immunosuppressant, ones who have been on antibiotic therapy, and the elderly population.
How do Antibiotics cause C diff.? The antibiotics cause a disruption in the normal intestinal flora which leads to an over growth of C difficile bacteria in the colon. The leading antibiotics known to disrupt the normal intestinal flora, yet not limited to, are Ampicillin, Amoxicillin, Cephalosporins, Clindamycin, and the broad spectrum antibiotics.
Since November 2012 the CDC has shared public announcements regarding antibiotic use: Colds and many ear and sinus infections are caused by viruses, not bacteria. Taking antibiotics to treat a “virus” can make those drugs less effective when you and your family really need them. Limiting the usage of antibiotics will also help limit new cases of CDI.
*Always discuss the symptoms and medications with the treating Physician.
What are C.diff. Symptoms? Symptoms of Clostridium difficile (C.diff.) C.diff. strains produce several toxins; the most popular are enterotoxin – Clostridium difficile toxin A and cytotoxin – Clostridium difficile toxin B. Both strains are responsible for the symptoms of diarrhea, abdominal pain, fever, fatigue, and can advance to a complication of a severe inflammation of the colon; pseudomembranous colitis, which can also lead to further complications of toxic megacolon.
How is C.diff. Transmitted? Mode of transmission of CDI can be either directly or indirectly, hospital acquired (nosocomial) or community – acquired; Ingesting C.diff spores transmitted from others and patients by hands, or altered normal intestinal flora by antibiotic therapy allowing proliferation of C.diff. in the colon. Coming in contact with surfaces, devices, or material with Clostridium difficile spores can easily be transferred to individuals by hands that have touched a contaminated surface or item. Examples of surfaces, devices, and materials contaminated with C.diff. spores in hospital and community/outpatient settings: commodes, bath tubs, showers, hand rails, bed rails, counter tops, handles, clothing, medical equipment, and electronic rectal thermometers.
The C Diff Foundation provide a wide range of programs, such as education, and advocacy for C. diff. infection prevention, treatments, support, and environmental safety worldwide, training of volunteer patient advocates (VPA’s) across the globe to provide educational workshops, supplying life-saving medications for those afflicted with this infection from young children to seniors, building satellite branches across the globe, presenting educational workshops in educational programs, improving and expanding the C. difficile infection awareness, providing global tele-conferencing support sessions in mental health counseling, long-term illnesses, the prevention, treatments, environmental safety with nutritional education for patients, and families suffering through a C. difficile infection
and so much more.
We are working together and dedicated at raising C. diff. awareness to witness a decrease in newly diagnosed C. difficile infections worldwide and through dedication and efforts of the
C Diff Foundation Volunteers – we will meet our goals.
Treatments For CDI? Treating C diff is becoming more challenging to physicians, frustrating to patients, and costly to the health care industry. To date there are three antibiotics effective at treating C diff: Metronidazole is prescribed to treat mild to moderate symptoms and is cost effective (8). Vancomycin is prescribed for moderate to severe symptoms via: oral route as intravenous administration does not achieve gut lumen therapeutic levels. Vancomycin is prescribed to patients with unsuccessful results from the Metronidazole, or the patient is allergic, or pregnant, breastfeeding, or younger than ten years of age.
The most recent antibiotic, Dificid (fidaxomicin) http://www.dificid.com is the first medication approved by FDA to treat C diff. Associated-Diarrhea CDAD in over twenty five years with superiority in sustained clinical response (5) Loperamide, diphenoxylate and bismuth medications are contraindicated as they slow the fecal transit time which extends the toxins in the gastrointestinal system.
The use of Cholestyramine has demonstrated positive results as toxins A and B bind to the resin as it passes through the intestines aiding in slowing bowel motility and assists in decreasing dehydration (9).
C.diff. spores are able to live outside of the body for a very long period of time and are resistant to most routine cleaning agents. It has also been proven that alcohol based hand sanitizers remain ineffective in eradicating C. diff. spores. In 2009 Clorox Commercial Solutions Ultra Clorox Germicidal Bleach ® was named the first and only product to obtain Federal EPA registration for killing C. diff. spores on hard, non porous surfaces when used as directed (1).
Please visit the following Page for additional information:
The CDC also recommends a 1:10 ( 1 cup bleach to 9 cups of water) dilution of bleach and water for cleaning hard non-porous surfaces keeping areas covered with solution for 10 minutes and the solution is to be mixed fresh daily.
Hand hygiene following the guidelines in HAND WASING; it is important to wash hands before entering and exiting a patient’s room (4). The spores are difficult to remove from hands; Universal Contact Precautions remain best practice for healthcare personnel and Contact Precautions for patients with a confirmed diagnosis of CDI. Prevention through education about CDI has proven effective and beneficial to environmental housekeeping departments, health care professionals, administration, patients, and their families (2)